BR112013006515A2 - vacina de combinação, e, método para a fabricação de uma vacina de combinação - Google Patents

vacina de combinação, e, método para a fabricação de uma vacina de combinação

Info

Publication number
BR112013006515A2
BR112013006515A2 BR112013006515A BR112013006515A BR112013006515A2 BR 112013006515 A2 BR112013006515 A2 BR 112013006515A2 BR 112013006515 A BR112013006515 A BR 112013006515A BR 112013006515 A BR112013006515 A BR 112013006515A BR 112013006515 A2 BR112013006515 A2 BR 112013006515A2
Authority
BR
Brazil
Prior art keywords
combination vaccine
manufacture
vaccines
combination
vaccine
Prior art date
Application number
BR112013006515A
Other languages
English (en)
Other versions
BR112013006515B1 (pt
Inventor
Ilona Reimann
Martin Beer
Patricia Koenig
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112013006515A2 publication Critical patent/BR112013006515A2/pt
Publication of BR112013006515B1 publication Critical patent/BR112013006515B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation
    • C12N2770/24362—Methods of inactivation or attenuation by genetic engineering

Abstract

vacina de combinação, e, método para a fabricação de uma vacina de combinação. a presente invneção se refere ao vírus bvd e aos seus usos, às vacinas e vacinas de combinação que compreendem um tal vírus, seu uso como um medicamento, seu uso no tratamento da diarréia viral bovina e aos métodos para a preparação de tais vacinas.
BR112013006515A 2010-09-21 2011-09-21 vacina de combinação, e, método para a fabricação de uma vacina de combinação BR112013006515B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38501010P 2010-09-21 2010-09-21
EP10177931 2010-09-21
PCT/EP2011/066377 WO2012038454A1 (en) 2010-09-21 2011-09-21 Bvdv vaccine

Publications (2)

Publication Number Publication Date
BR112013006515A2 true BR112013006515A2 (pt) 2016-08-02
BR112013006515B1 BR112013006515B1 (pt) 2020-04-28

Family

ID=43110616

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013006515A BR112013006515B1 (pt) 2010-09-21 2011-09-21 vacina de combinação, e, método para a fabricação de uma vacina de combinação

Country Status (11)

Country Link
US (1) US9878030B2 (pt)
EP (1) EP2618841B1 (pt)
CN (1) CN103338785B (pt)
AU (1) AU2011306957C1 (pt)
BR (1) BR112013006515B1 (pt)
CA (1) CA2811243C (pt)
ES (1) ES2606605T3 (pt)
MX (1) MX347911B (pt)
RU (1) RU2578943C2 (pt)
WO (1) WO2012038454A1 (pt)
ZA (1) ZA201301950B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103338785B (zh) 2010-09-21 2015-01-14 英特维特国际股份有限公司 Bvdv疫苗
WO2014043215A1 (en) 2012-09-11 2014-03-20 The Texas A&M University System Bi-specifc diabodies for masking and targeting vaccines
CN105949286A (zh) * 2016-07-04 2016-09-21 中国兽医药品监察所 牛病毒性腹泻病毒i型e2蛋白的表达及应用
CN108456663B (zh) * 2018-03-26 2021-09-21 中国农业科学院兰州兽医研究所 一种1型牛病毒性腹泻病毒样颗粒及其制备与应用
CN108614121B (zh) * 2018-05-04 2020-11-20 山东师范大学 牛病毒性腹泻病毒e2蛋白抗原多表位融合肽及其制备与应用
CN111533813B (zh) * 2020-07-09 2020-10-16 苏州世诺生物技术有限公司 牛病毒性腹泻病毒重组亚单位疫苗
CN113403256B (zh) * 2021-06-16 2023-04-18 中国农业科学院特产研究所 一种稳定产生牛病毒性腹泻病毒抗原的细胞系及抗体胶体金检测试纸条的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001613A (en) 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
EP0965639A1 (en) 1998-06-05 1999-12-22 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US6168942B1 (en) 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (en) 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
CA2363493C (en) 2000-11-22 2006-06-06 Xuemei Cao Attenuated forms of bovine viral diarrhea virus
US6974575B2 (en) * 2001-08-28 2005-12-13 Pfizer Inc. Generation of type I/type II hybrid form of bovine viral diarrhea virus for use as vaccine
DE10143813A1 (de) 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon
EP1727562B1 (en) * 2004-03-17 2008-06-18 Pharmacia & Upjohn Company LLC Method of vaccination against testicular bvdv infection
DE102004025452A1 (de) * 2004-05-19 2006-01-19 Boehringer Ingelheim Vetmedica Gmbh Vakzine enthaltend BVDV
UY29915A1 (es) 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
RU2524426C2 (ru) * 2008-12-03 2014-07-27 Пфайзер Инк. ВИРУС ДИАРЕИ КРУПНОГО РОГАТОГО СКОТА С МОДИФИЦИРОВАННЫМ БЕЛКОМ Erns
CN103338785B (zh) 2010-09-21 2015-01-14 英特维特国际股份有限公司 Bvdv疫苗

Also Published As

Publication number Publication date
ZA201301950B (en) 2014-03-26
ES2606605T3 (es) 2017-03-24
US20130195892A1 (en) 2013-08-01
EP2618841B1 (en) 2016-10-19
CN103338785A (zh) 2013-10-02
AU2011306957B2 (en) 2014-07-24
CN103338785B (zh) 2015-01-14
CA2811243C (en) 2019-03-05
RU2578943C2 (ru) 2016-03-27
BR112013006515B1 (pt) 2020-04-28
EP2618841A1 (en) 2013-07-31
WO2012038454A1 (en) 2012-03-29
AU2011306957C1 (en) 2014-08-28
AU2011306957A1 (en) 2013-04-11
RU2013118351A (ru) 2014-10-27
MX2013003245A (es) 2013-05-22
MX347911B (es) 2017-05-17
US9878030B2 (en) 2018-01-30
CA2811243A1 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
BR112013006515A2 (pt) vacina de combinação, e, método para a fabricação de uma vacina de combinação
BR112012020839A2 (pt) vacinas para uso na profilaxe e tratamento de doença de vírus da influenza
BR112018000862A2 (pt) composições de vacina
EP4233898A3 (en) Influenza mrna vaccines
BR112018008102A2 (pt) vacina de vírus sincicial respiratório
ECSP15019323A (es) Derivados de 5-fluoro-n-(piridin-2-il)piridin-2-amina que contienen un grupo sulfoximina
CL2013002712A1 (es) Composicion inmunogénica para modular sistema inmune que comprende agentes con patrones asociados a bacterias, virus, hongos y levaduras, protozoos, helmintos y/o priones; uso para tratar enfermedades autoinmunes o infecciosas.
BR112015014482A2 (pt) vacinas para vírus influenza e seus usos
BR112013011194A2 (pt) partículas de glicoproteína semelhantes a vírus (vlps) da raiva.
ECSP14013315A (es) Inhibidores de aplicación viral
ECSP12011834A (es) Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, métodos para su tratamiento y sus usos.
PE20151588A1 (es) Vacuna contra el virus del dengue
MX349119B (es) Vacuna de virus de dengue inactivado.
MY194294A (en) Novel viral replication inhibitors
PH12015501333A1 (en) Method of making a mycoplasma vaccine
MX2015007753A (es) Composicion de vacunas para sujetos intactos.
BR112012030659A2 (pt) parvovírus vivo atenuado, vacina, e, métodos para a fabricação de uma vacina, e para a preparação de um parvovírus mutante.
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
NZ630831A (en) Compositions and methods for administration of vaccines against dengue virus
CL2014003113A1 (es) Composición que comprende bacterias inactivadas de alliivibrio wodanis; método de producción; uso para fabricar medicamento para tratar y/o prevenir wodanosis; y vacuna para peces.
CL2016000787A1 (es) Composición farmacéutica en forma de comprimido que comprende atazanavir y cobicistat; procedimiento de preparación; y uso de la composición para preparar un medicamento útil para tratar la infección por el virus de inmunodeficiencia humana (vih).
EA201491845A1 (ru) Получение стерильных активных фармацевтических ингредиентов
AR082577A1 (es) Vacunas de virus varicela zoster inactivado, metodos de produccion y uso de las mismas
BR112015008040A2 (pt) composição de vacina, vacina de combinação, e, processos para preparar um componente ap e para a fabricação de uma composição de vacina
BR112014028632A8 (pt) Composto, composição farmacêutica, e, método para preparar um composto

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/09/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2688 DE 12-07-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.